Milan, Italy

Giancarlo Dona


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Giancarlo Dona: Innovator in Cardiovascular Treatments**

Introduction

Giancarlo Dona is an accomplished inventor based in Milan, Italy, known for his significant contributions to the field of pharmaceuticals. With a focus on the treatment of cardiovascular diseases, Dona has successfully developed innovative compounds that hold promise in healthcare.

Latest Patents

Dona’s most notable patent is related to benzoxazinone and benzothiazinone derivatives, specifically designed for cardiovascular applications. The patent encompasses compounds of formula I, wherein various substituents including hydrogen, alkyl groups, cycloalkyl, and phenyl can be utilized. These compounds, alongside their pharmaceutically acceptable salts, are outlined for use in treating cardiovascular diseases, marking a vital advancement in pharmaceutical science.

Career Highlights

Giancarlo Dona currently works with Italfarmaco Spa, an esteemed company in the pharmaceutical sector. His research and innovative spirit have enabled him to harness his knowledge in chemistry and pharmacology towards developing effective cardiovascular treatments.

Collaborations

Dona has collaborated with notable coworkers, including Alberto Sala and Roberto Barani. These partnerships have allowed for a synergy of ideas, enhancing the quality and impact of their joint research within the pharmaceutical industry.

Conclusion

In conclusion, Giancarlo Dona stands out as a pivotal figure in the realm of cardiovascular therapeutics. Through his patent innovations and collaborations, he continues to contribute to the advancement of life-saving medical treatments. His work at Italfarmaco Spa solidifies his role as a key player in pharmaceutical innovation, with the potential to change the lives of many affected by cardiovascular diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…